Other Events ·
Dyadic International, Inc. received a notification from Nasdaq on June 18, 2026, initiating delisting proceedings due…
DYAIDyadic International Inc
Dyadic International, Inc. received a notification from Nasdaq on June 18, 2026, initiating delisting proceedings due to failure to comply with the Bid Price Rule, which requires a minimum $1.00 share price. The company failed to regain compliance by the June 17, 2026, deadline and did not meet the $5 million shareholders' equity requirement necessary for an extension. Additionally, the company is in violation of Continued Listing Standards regarding minimum equity, market value, or net income. Dyadic plans to request a hearing before an independent Nasdaq hearings panel to seek an extension through December 15, 2026. Dyadic International, Inc. is a biotechnology company focused on microbial protein production platforms.